Table 1.
Patient demographics and tumour data
| Patient No | Age | Sex | DM | HTN | Additional ocular disease | Eye | Tumour location | Size (mm) | TNM | ||
| Laser group | Length | Width | Height | ||||||||
| With retinopathy | |||||||||||
| 1 | 63 | F | – | Y | – | RE | 530EP | 12 | 9 | 2.8 | T2N0M0 |
| 2 | 72 | M | – | – | Glaucoma | LE | 230EP | 9 | 10 | 4.9 | T2N0M0 |
| 3 | 84 | M | – | – | – | LE | 3EP | 10 | 12 | 4.2 | T2N0M0 |
| 4 | 52 | M | – | – | – | RE | 9EP | 10.3 | 11 | 5.3 | T2N0M0 |
| 5 | 56 | F | – | – | – | RE | 1EP | 7 | 8 | 2.4 | T1N0M0 |
| 6 | 81 | F | – | – | – | RE | 9EP | 7 | 12 | 3.6 | T2N0M0 |
| 7 | 67 | M | – | Y | – | LE | 230E | 14 | 12.5 | 6.5 | T2N0M0 |
| 8 | 86 | M | – | – | – | LE | 11E | 10 | 12 | 6.2 | T2N0M0 |
| 9 | 84 | F | – | – | – | LE | 430EP | 6 | 8 | 4.4 | T1N0M0 |
| 10 | 86 | M | – | Y | ARMD | RE | 1030EP | 12 | 10 | 2.9 | T2N0M0 |
| 11 | 34 | F | – | – | – | RE | 1PE | 5 | 6 | 1.9 | T1N0M0 |
| 12 | 72 | M | Y | Y | BDR | LE | 3EP | 14 | 16 | 3.4 | T2N0M0 |
| 13 | 86 | F | – | Y | – | RE | 1030EP | 14 | 15 | 5.2 | T2N0M0 |
| 14 | 72 | M | Y | – | – | LE | 230EP | 10 | 10 | 3.4 | T2N0M0 |
| 15 | 58 | F | – | – | – | LE | 1P | 7 | 10 | 3.2 | T2N0M0 |
| 16 | 81 | M | Y | – | – | RE | 230P | 8 | 10 | 4.1 | T2N0M0 |
| 17 | 55 | F | – | Y | – | LE | 230P | 6 | 6 | 2.4 | T1N0M0 |
| 18 | 68 | F | – | – | – | LE | 9EP | 10 | 10 | 5.4 | T2N0M0 |
| 19 | 86 | F | Y | Y | ARMD | RE | 730EP | 12 | 13 | 5.4 | T2N0M0 |
| 20 | 85 | F | – | – | Glaucoma | LE | 130EP | 8 | 10 | 2.4 | T2N0M0 |
| 21 | 86 | F | – | – | – | RE | 9EP | 9 | 10 | 2.7 | T2N0M0 |
| 22 | 71 | F | – | – | – | RE | 1030EP | 8 | 9 | 2.4 | T1N0M0 |
| 23 | 87 | F | – | Y | – | LE | 11PE | 6 | 8 | 3.2 | T1N0M0 |
| 24 | 59 | F | – | – | – | LE | 230EP | 8 | 10 | 3 | T2N0M0 |
| 25 | 62 | F | – | Y | – | LE | 9EP | 10 | 10 | 3.5 | T2N0M0 |
| 26 | 83 | F | – | – | – | LE | 430EP | 9 | 9 | 2.9 | T1N0M0 |
| 27 | 59 | M | – | – | – | LE | 4EP | 10 | 12 | 2.7 | T2N0M0 |
| 28 | 87 | F | Y | Y | BDR | RE | 430EP | 10 | 10 | 2.7 | T2N0M0 |
| 29 | 82 | F | – | Y | Glaucoma | LE | 3EP | 6 | 6 | 3.5 | T1N0M0 |
| 30 | 84 | M | – | – | ARMD | LE | 3EP | 8 | 8 | 3.2 | T1N0M0 |
| 31 | 82 | M | – | – | ARMD | LE | 430EP | 9 | 12 | 3.4 | T2N0M0 |
| 32 | 66 | F | – | Y | – | RE | 9EP | 10 | 14 | 4.4 | T2N0M0 |
| 33 | 70 | M | – | – | – | RE | 10EP | 10 | 10 | 2.9 | T2N0M0 |
| 34 | 55 | M | – | – | – | RE | 5P | 7 | 8 | 5 | T1N0M0 |
| 35 | 82 | F | Y | Y | – | LE | 230EP | 12 | 10 | 3.4 | T2N0M0 |
| 36 | 68 | F | – | – | – | RE | 6PE | 14 | 12 | 5.8 | T2N0M0 |
| 37 | 59 | M | – | Y | – | RE | 11P | 8 | 8 | 2.4 | T1N0M0 |
| 38 | 87 | M | – | Y | – | RE | 9EP | 10 | 10 | 4.7 | T2N0M0 |
| 39 | 73 | F | Y | Y | – | RE | 3EP | 12 | 12 | 3.4 | T2N0M0 |
| 40 | 54 | M | – | – | – | RE | 9EP | 5 | 7 | 2.4 | T1N0M0 |
| 41 | 66 | M | – | – | ARMD | RE | 4PE | 9 | 9 | 3.7 | T1N0M0 |
| 42 | 86 | F | – | – | – | LE | 9P | 7 | 8 | 3.2 | T1N0M0 |
| 43 | 79 | M | – | – | Glaucoma | LE | 130EP | 9.9 | 10 | 2.9 | T2N0M0 |
| 44 | 94 | F | Y | Y | – | LE | 3EP | 10 | 10 | 2.4 | T1N0M0 |
| 45 | 79 | F | – | – | – | LE | 430EP | 10 | 10 | 2.7 | T2N0M0 |
| Prophylactic group | |||||||||||
| 1 | 53 | F | – | – | – | RE | 1030EP | 10 | 16 | 4 | T2N0M0 |
| 2 | 66 | M | – | – | – | LE | 2EP | 9 | 9 | 2.4 | T1N0M0 |
| 3 | 78 | F | – | – | – | LE | 9EP | 10.5 | 8 | 3 | T2N0M0 |
| 4 | 31 | M | – | – | – | LE | 1P | 9 | 10 | 3.6 | T2N0M0 |
| 5 | 82 | F | – | Y | – | RE | 6E | 12 | 13 | 3.2 | T2N0M0 |
| 6 | 51 | M | – | – | – | RE | 12P | 4 | 6 | 2.2 | T1N0M0 |
| 7 | 59 | F | – | – | – | LE | 2EP | 11 | 13 | 3.6 | T2N0M0 |
| 8 | 83 | F | – | – | Glaucoma | LE | 2EP | 9 | 11 | 2.7 | T2N0M0 |
| 9 | 70 | M | Y | – | – | LE | 9E | 12 | 16 | 4.9 | T2N0M0 |
| 10 | 77 | F | – | – | Glaucoma | RE | 1030EP | 6 | 7 | 2.5 | T1N0M0 |
| 11 | 67 | F | – | – | ARMD | RE | 3PE | 7 | 8 | 2 | T1N0M0 |
| 12 | 68 | M | – | – | – | LE | 5EP | 9 | 10 | 3.6 | T2N0M0 |
| 13 | 47 | M | – | – | Glaucoma/BRVO | RE | 3PE | 6 | 7 | 2.7 | T1N0M0 |
| 14 | 86 | F | – | Y | ARMD | RE | 730EP | 7 | 10 | 2.4 | T1N0M0 |
| 15 | 87 | M | – | Y | Glaucoma | RE | 9P | 8 | 8 | 2.8 | T1N0M0 |
| 16 | 82 | F | Y | Y | BDR | RE | 1030EP | 11 | 11 | 2.6 | T2N0M0 |
DM, diabetes mellitus; HTN, hypertension; ARMD, age related macular degeneration; BDR, background diabetic retinopathy; BRVO, branch retinal vein occlusion; E, equator; P, posterior; TNM, AJCC-UICC classification.